NCT00053001 2013-06-26Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic SyndromeNational Cancer Institute (NCI)Phase 2 Completed
NCT00030550 2013-01-31Thalidomide in Treating Anemia in Patients With Myelodysplastic SyndromeRoswell Park Cancer InstitutePhase 2 Completed
NCT00445900 2011-03-17Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid MetaplasiaMayo ClinicPhase 2 Completed22 enrolled
NCT00053287 2010-06-10Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDSCase Comprehensive Cancer CenterPhase 2 Completed42 enrolled